Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Share Awards

20 Oct 2014 17:09

RNS Number : 8075U
Wilmington Group Plc
20 October 2014
 



20 October 2014

Wilmington Group plc

Share Awards

As previously announced, in October 2011, Wilmington Group plc (the "Company") granted a number of share awards under its Performance Share Plan ("PSP"). The vesting of these awards was conditional upon the achievement of certain performance criteria. As a result of the Company's performance over the three years to 30 June 2014, 701,637 ordinary shares of 5 pence each vested on 19 October 2014 in favour of a total of 57 employees of the company (including Directors) ("Vested Shares").

On 19 October, a further 81,693 ordinary shares of 5 pence each were allocated under the PSP scheme rules to reflect the value of the dividend that would have been paid had the vested shares been issued in October 2011 ("Dividend Shares").

379,006 of the required 783,330 Vested Shares and Dividend Shares have been satisfied from existing treasury shares. In accordance with Section 551 of the Companies Act 2006 and under the authority of its shareholders, the directors have issued a further 404,324 ordinary voting shares to satisfy the Company's obligations under the PSP. Application has been made to the UK Listing Authority and the London Stock Exchange for 404,324 ordinary shares of 5 pence each to be admitted to the Official List and to trading on the Main Market. It is expected that trading will commence on 24 October 2014. These shares will rank pari passu with the existing issued shares of the Company.

Following the issue of further ordinary shares of 5 pence each and the re issue of treasury shares the Company now has issued voting share capital of 86,886,467 ordinary shares of 5 pence each.

The Directors and employees have to pay tax at their marginal income tax rates on the value of the shares awarded to them. Under Shareholding guidelines for Executives, which the Company has adopted, Executives are expected to retain 50% of vested shares (net of taxes) until such time as their personal shareholding reaches the equivalent of 100% of the pre-tax base salary. Neil Smith, an executive director, having exceeded the guidance, has sold all his 2011 Vested Shares (66,954) and 2011 Dividend (7,796) Shares. The sales occurred on 20 October 2014 in London at an average of 215 pence per share.

Linda Wake, Deputy Group Finance Director has elected to sell 19,977 ordinary shares of 5 pence each to settle her resulting tax liability and keep the remaining ordinary shares beneficially. She received 42,505 ordinary shares of 5 pence each of which she will retain 22,527. The sale occurred on 20 October 2014 in London at an average of 215 pence per share.

As a result of this, in accordance with DTR 3.1.2,

- Charles Brady has acquired a further 117,390 ordinary shares in the Company under the 2011 PSP bringing his resultant holding of ordinary shares of 5 pence each to 31,938,919 which is 3.68% of the issued share capital with voting rights.

- Linda Wake has acquired 22,527 ordinary shares of 5 pence each in the Company bringing her resultant holding of ordinary shares of 5 pence each to 39,856 which is 0.05% of the issued share capital with voting rights.

- Neil Smith retains his existing 401,338 shares which is 0.46% of the issued share capital with voting rights.

 

Anthony Foye

Chief Financial Officer

 

For further information please contact:

Wilmington Group plc

020 7422 6800

Pedro Ros, Chief Executive

Tony Foye, Finance Director

FTI Consulting

020 3727 1000

Charles Palmer / Emma Appleton

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKKDKABDDFKB
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.